|
Volumn 56, Issue 9, 2001, Pages 916-917
|
Tolerability of rofecoxib
|
Author keywords
COX 2 inhibitors; Drug allergy; Nonsteroidal anti inflammatory drugs; Rofecoxib; Urticaria
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
HISTAMINE;
LEUKOTRIENE;
LEUKOTRIENE B4;
LIPOXYGENASE;
NIMESULIDE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PARACETAMOL;
PEPTIDOLEUKOTRIENE;
PLACEBO;
ROFECOXIB;
ADULT;
AGED;
ANGIONEUROTIC EDEMA;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG HYPERSENSITIVITY;
DRUG TOLERABILITY;
ENZYME INHIBITION;
FEMALE;
HISTAMINE RELEASE;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROVOCATION TEST;
SINGLE BLIND PROCEDURE;
URTICARIA;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CYCLOOXYGENASE INHIBITORS;
DRUG TOLERANCE;
FEMALE;
HUMANS;
LACTONES;
MALE;
MIDDLE AGED;
SULFONES;
URTICARIA;
|
EID: 0034866095
PISSN: 01054538
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1398-9995.2001.00300.x Document Type: Article |
Times cited : (45)
|
References (12)
|